Last Thursday, BIOVEGEN held a new meeting of its General Assembly. The event also included the session “Technological Trends and Funding for Plant R&D+i,” which addressed future applications in the market for genomic editing and the funding opportunities for the plant innovation sector opened up by the NEXT GENERATION EU funds. During the subsequent Colloquium, BIOVEGEN members had the opportunity to pose their questions to the speakers.
Agenda:
11:00 a.m. Welcome and introduction
11:10 a.m. BIOVEGEN General Assembly
- Reading of the Minutes from the previous Assembly
- Ratification of new members
- Activity Report and Action Plan 2021-2022
- Economic Situation and Budget 2021-2022
- Various matters
- Questions and comments
12:00 p.m. Session “Technological Trends and Funding for Plant R&D+i”
- Genomic editing: future applications in international markets. Emilio Rodríguez-Cerezo. Joint Research Centre, European Commission.
- Funding for plant innovation. NEXT GENERATION funds, PERTE AGRO. Luis Socías Uribe. Office of European Projects, CEOE.
12:50 p.m. Colloquium with BIOVEGEN members